RECRUITING

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.

Official Title

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

Quick Facts

Study Start:2018-12-02
Study Completion:2026-12-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05810220

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Hearing impaired adult and or child (above 2 years old) who uses ABIs or cochlear implants.
  2. * No diagnosis of any other communicative or cognitive disorder other than hearing impairment. The individual must be able to visit the lab in order to participate in behavioral and electrophysiological experiments.
  3. * Patients' implant device must have useable electrodes that do not result in uncomfortable or unpleasant non-auditory sensation.
  1. * Diagnosed cognitive or communicative disorders (other than hearing impairment)
  2. * Severe neurological disorders
  3. * No useable electrodes in their implants

Contacts and Locations

Study Contact

Mahan Azadpour
CONTACT
2122637785
Mahan.Azadpour@nyulangone.org

Principal Investigator

Mahan Azadpour
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Mahan Azadpour, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-12-02
Study Completion Date2026-12-30

Study Record Updates

Study Start Date2018-12-02
Study Completion Date2026-12-30

Terms related to this study

Additional Relevant MeSH Terms

  • Deafness